Rewriting the Rules of Medicine
The Safe,
Generalizable
& Precise Future
for Genetic Medicine
About Us
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.
The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population.
Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Safe
Reversible
Larger Edits
Our Values
Biologically Inspired
Biology is the most sophisticated and specialized form of technology accessible to our species. We humbly study biological systems, learn from them, and put them back together in new ways to build technologies to improve health.
Designed with Artisanship
We blend complex science with biological design. Our work is made possible by approaching biology through an artisan lens, allowing us to explore new avenues, discover novel connections, and advance meaningful paradigms.
Driven by Impact
We believe in a future where life’s most complex diseases are treated at scale. Gene therapies should be safe, easy, precise, and affordable. We work backwards from impact, building out a new frontier of genetic medicine.
Meet The Team
Supported by a vibrant and diverse group of scientists and industry experts. United by a shared vision of enhancing the therapeutic toolkit.
Awilda Rosario
Principal Bioarchitect
Bret Peterson, PhD
Bioarchitect III
David Schaffer, PhD
SAB
David Yao, PhD
Bioarchitect III
Federico Mingozzi, PhD
SAB
Fei Chen, PhD
SAB
Gene Yeo, PhD
SAB
Jacob Borrajo, PhD
CEO and Co-Founder
Jim Griffin, PhD
Senior Computational Biologist
Jory Bell
Board Member
Kaisle Hill
Biodesigner III
Kamyab Javanmardi, PhD
VP of Platform
Kevin Goncalves, PhD
Bioarchitect I
Makala Keys
HR Business Partner
Melissa Jurica, PhD
SAB
Nicholas Henninger
Biodesigner III
Nicholas Reynolds
Biodesigner III
Patty Biezonski, PhD
VP of Development
Paul Blainey, PhD
SAB
Puloma Sen
Associate Bioarchitect
Sam DeMario, PhD
Bioarchitect II
Tou Lee
Lab Manager
Vineeta Agarwala, MD, PhD
Board Member